[1]杨成艳,李新培,马晓庆.孤立性促肾上腺皮质激素缺乏症的诊疗进展[J].国际内分泌代谢杂志,2023,43(03):211-215.[doi:10.3760/cma.j.cn121383-20220420-04050]
 Yang Chengyan,Li Xinpei,Ma Xiaoqing..The progress of diagnosis and treatment of isolated adrenocorticotropic hormone deficiency[J].International Journal of Endocrinology and Metabolism,2023,43(03):211-215.[doi:10.3760/cma.j.cn121383-20220420-04050]
点击复制

孤立性促肾上腺皮质激素缺乏症的诊疗进展()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
43
期数:
2023年03期
页码:
211-215
栏目:
综述
出版日期:
2023-05-20

文章信息/Info

Title:
The progress of diagnosis and treatment of isolated adrenocorticotropic hormone deficiency
作者:
杨成艳1李新培2马晓庆3
1山东第一医科大学研究生部,济南 250000; 2济宁医学院临床医学院,济宁 272100; 3济宁市第一人民医院内分泌科,济宁 272100
Author(s):
Yang Chengyan1 Li Xinpei2 Ma Xiaoqing3.
1Graduate Department, Shandong First Medical University, Jinan 250000, China; 2Clinical Medical College, Jining Medical University, Jining 272100, China; 3Department of Endocrinology, Jining First People's Hospital, Jining 272100, China
关键词:
孤立性促肾上腺皮质激素缺乏症 发病机制 诊疗
Keywords:
Isolated adrenocorticotropic hormone deficiency Pathogenesis Diagnosis and treatments
DOI:
10.3760/cma.j.cn121383-20220420-04050
摘要:
孤立性促肾上腺皮质激素缺乏症(IAD)是一种罕见病,表现为单纯的下丘脑-垂体-肾上腺轴受累,血清皮质醇水平降低,促肾上腺皮质激素水平绝对或相对不足,甲状腺轴、生长激素轴及性腺轴功能正常。IAD的具体发病机制尚不明确,可能与机体自身免疫性破坏、垂体缺血性损伤、促肾上腺皮质激素释放激素缺乏、POMC基因缺陷、转录因子基因突变、激素原转化酶1结构突变,以及药物性损伤有关; IAD的临床表现缺乏特异性,成人及部分型的IAD患者多表现为乏力、纳差、恶心,以及不同程度的低血糖、低血钠,完全型IAD的患者症状相对较重,常见有严重低血糖、癫痫发作、胆汁淤积性黄疸; IAD的诊断关键在于腺垂体和靶腺激素水平的测定,治疗以补充糖皮质激素为主。临床上,很多患者症状反复发作,长期得不到确诊,严重影响了生活质量。因此,本综述通过对IAD临床特点的讨论,以提高医生对该疾病的认识,使患者能够得到早期诊断、早期治疗,获得良好的预后。
Abstract:
Isolated adrenocorticotropic hormone deficiency(IAD)is a rare disease characterized by pure involvement of the hypothalamus-pituitary-adrenal axis, decreased serum cortisol level, absolute or relative deficiency of adrenocorticotropic hormone(ACTH)level, but normal functions of the thyroid axis, growth hormone axis and gonad axis. The specific pathogenesis of IAD is still unclear, and may be related to autoimmune destruction, ischemic injure to the pituitary, CRH deficiency, POMC gene defects, transcription factor gene mutations, abnormal structure of PC1, and drug-related injuries. The clinical manifestations of IAD are lack of specificity; adult idiopathic isolated ACTH deficiency patients and partial congenital isolated ACTH deficiency patients mostly manifested as fatigue, poor appetite, nausea, varying degrees of hypoglycemia and hyponatremia. Patients with complete congenital isolated ACTH deficiency have relatively severe symptoms, including severe hypoglycemia, seizures, and cholestatic jaundice. The key to the diagnosis of IAD is to measure the hormone levels of pituitary and target gland, and glucocorticoid supplementation is the main treatment. Many IAD patients remain undiagnosed for a long time, which seriously affects the quality of their life. Therefore, this paper systematically describes the characteristics of IAD to improve our understanding of the disease, so that patients can receive early diagnosis and treatments and obtain a good prognosis.

参考文献/References:

[1] Morigaki Y,Iga J,Kameoka N,et al.Psychiatric symptoms in a patient with isolated adrenocorticotropin deficiency: case report and literature review[J].Gen Hosp Psychiat,2014,36(4):449.e3-5.DOI:10.1016/j.genhosppsych.2014.02.012.
[2] Hannon AM,Hunter S,Smith D,et al.Clinical features and autoimmune associations in patients presenting with Idiopathic Isolated ACTH deficiency[J].Clin Endocrinol(Oxf),2018,88(3):491-497.DOI:10.1111/cen.13536.
[3] Fujita Y,Bando H,Iguchi G,et al.Clinical heterogeneity of acquired idiopathic isolated adrenocorticotropic Hormone Deficiency[J].Front Endocrinol(Lausanne),2021,12:578802.DOI:10.3389/fendo.2021.578802.
[4] Ishizuka T,Asano M,Fujioka K,et al.Two cases of traumatic isolated ACTH deficiency[J].Int J Clin Endocrinol Metab,2018,4(1):004-007.DOI:10.17352/ijcem.000030.
[5] Iglesias P,Peiró I,Biagetti B,et al.Immunotherapy-induced isolated ACTH deficiency in cancer therapy[J].Endocr Relat Cancer,2021,28(12):783-792.DOI:10.1530/ERC-21-0228.
[6] Chiloiro S,Giampietro A,Bianchi A,et al.Empty sella syndrome:Multiple endocrine disorders[J].Handb Clin Neurol,2021,181:29-40.DOI:10.1016/B978-0-12-820683-6.00003-8.
[7] 朱斌,王守森.垂体的组织构筑及血供分布[J].中华解剖与临床杂志,2019,24(6):634-638.DOI:10.3760/cma.j.issn.2095-7041.2019.06.023.
[8] 殷和佳,赵豫梅.2型糖尿病合并孤立性ACTH缺乏症和原发性甲减漏诊一例[J].实用糖尿病杂志,2018,14(5):15-16.
[9] Candler T,Kühnen P,Prentice AM,et al.Epigenetic regulation of POMC; implications for nutritional programming,obesity and metabolic disease[J].Front Neuroendocrinol,2019,54:100773.DOI:10.1016/j.yfrne.2019.100773.
[10] Weijing K,Liping Z,Tiantian Z,et al.A case of congenital isolated adrenocorticotropic hormone deficiency caused by two novel mutations in the TBX19 gene[J].Front Endocrinol(Lausanne),2019,10:251.DOI:10.3389/fendo.2019.00251.
[11] Kardelen Al AD,Poyrazogˇlu瘙塁,Aslanger A,et al.A rare cause of adrenal Insufficiency-Isolated ACTH deficiency due to TBX19 mutation:long-term follow-up of two cases and review of the literature[J].Horm Res Paediatr,2019,92(6):395-403.DOI:10.1159/000506740.
[12] Shi C,Wang F,Tong A,et al.NFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiency:a case report and review of literature[J].Medicine(Baltimore),2016,95(40):e5081.DOI:10. 1097/MD.0000000000005081.
[13] Rose M,Duhamel M,Rodet F,et al.The role of proprotein convertases in the regulation of the function of immune cells in the oncoimmune response[J].Front Immunol,2021,12:667850.DOI:10.3389/fimmu.2021.667850.
[14] Nussey SS,Soo SC,Gibson S,et al.Isolated congenital ACTH deficiency:a cleavage enzyme defect?[J]Clin Endocrinol(Oxf),1993,39(3):381-385.DOI:10.1111/j.1365-2265.1993.tb02381.x.
[15] Raj R,Jacob A,Elshimy G,et al.Isolated adrenocorticotropic hormone deficiency secondary to chronic opiate use[J].Cureus,2020,12(7):e9270.DOI:10.7759/cureus.9270.
[16] Müssig K,Friess E,Wudy SA,et al.Secondary adrenal failure due to long-term treatment with flunitrazepam[J].Clin Endocrinol(Oxf),2006,65(4):549-550.DOI:10.1111/j.1365-2265.2006.02622.x.
[17] Matsuo K,Koga M,Oishi M,et al.Cognitive impairment caused by isolated adrenocorticotropic hormone deficiency without other Hypo-adrenalism Signs-Autoimmune encephalopathy mimics[J].Intern Med,2020,59(1):119-120.DOI:10.2169/internalmedicine.3234-19.
[18] 中华医学会内分泌学分会肥胖学组.肾上腺皮质功能减退症患者围手术期糖皮质激素管理专家共识[J].中华内分泌代谢杂志,2022,38(1):1-6.DOI:10.3760/cma.j.cn311282-20210618-00386.
[19] Iglesias P,Sánchez JC,Díez JJ.Isolated ACTH deficiency induced by cancer immunotherapy:a systematic review[J].Pituitary,2021,24(4):630-643.DOI:10.1007/s11102-021-01141-8.
[20] Takayasu S,Mizushiri S,Watanuki Y,et al.Eosinophil counts can be a predictive marker of immune checkpoint inhibitor-induced secondary adrenal insufficiency:a retrospective cohort study[J].Sci Rep,2022,12(1):1294.DOI:10.1038/s41598-022-05400-x.
[21] Takeno A,Yamamoto M,Morita M,et al.Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab:a case report[J].BMC Endocr Disord,2019,19(1):25.DOI:10.1186/s12902-019-0335-x.
[22] Husebye ES,Pearce SH,Krone NP,et al.Adrenal insufficiency[J].Lancet,2021,397(10274):613-629.DOI:10.1016/S0140-6736(21)00136-7.
[23] 宁泽乾.拟微重力三维培养体系在腺垂体来源细胞培养中的应用研究[D].广州:广东药科大学,2020.DOI:10.27690/d.cnki.ggdyk.2020.000083.

相似文献/References:

[1]罗凯明 蒋晓红 华飞.糖尿病对肿瘤发生的影响及机制[J].国际内分泌代谢杂志,2020,40(02):125.[doi:10.3760/cma.j.issn.1673-4157.2020.02.013]
 Luo Kaiming,Jiang Xiaohong,Hua Fei.Effects and mechanisms of diabetes on tumorigenesis[J].International Journal of Endocrinology and Metabolism,2020,40(03):125.[doi:10.3760/cma.j.issn.1673-4157.2020.02.013]
[2]杨小颖 唐露霖 尚文斌.表观遗传修饰在自身免疫性甲状腺疾病发病中的作用[J].国际内分泌代谢杂志,2020,40(03):169.[doi:10.3760/cma.j.issn.1673-4157.2020.03.006]
 Yang Xiao-ying,Tang Lulin,Shang Wenbin.The role of epigenetic modification in the pathogenesis of autoimmune thyroid disease[J].International Journal of Endocrinology and Metabolism,2020,40(03):169.[doi:10.3760/cma.j.issn.1673-4157.2020.03.006]
[3]马晓森,童安莉.嗜铬细胞瘤分子病因学研究进展[J].国际内分泌代谢杂志,2021,41(02):82.[doi:10.3760/cma.j.cn121383-20200630-06087]
 Ma Xiaosen,Tong Anli..Research progress on the molecular etiology of pheochromocytoma[J].International Journal of Endocrinology and Metabolism,2021,41(03):82.[doi:10.3760/cma.j.cn121383-20200630-06087]
[4]王慧萍,童安莉.原发性醛固酮增多症相关的基因突变研究进展[J].国际内分泌代谢杂志,2021,41(02):87.[doi:10.3760/cma.j.cn121383-20200706-07013]
 Wang Huiping,Tong Anli..Research progress on gene mutation related primary aldosteronism[J].International Journal of Endocrinology and Metabolism,2021,41(03):87.[doi:10.3760/cma.j.cn121383-20200706-07013]
[5]戴媛,吴文君.T2DM骨骼肌病变的研究进展[J].国际内分泌代谢杂志,2021,41(04):352.[doi:10.3760/cma.j.cn121383-20200622-06061]
 Dai yuan,Wu Wenjun..Research progress on the type 2 diabetic myopathy[J].International Journal of Endocrinology and Metabolism,2021,41(03):352.[doi:10.3760/cma.j.cn121383-20200622-06061]
[6]赵津,蔡永红,张莲,等.糖尿病肾脏病发病机制的探讨[J].国际内分泌代谢杂志,2024,44(03):189.[doi:10.3760/cma.j.cn121383-20231030-10054]
 Zhao Jin,Cai Yonghong,Zhang Lian,et al.Research progress on pathogenesis of diabetic kidney disease[J].International Journal of Endocrinology and Metabolism,2024,44(03):189.[doi:10.3760/cma.j.cn121383-20231030-10054]

备注/Memo

备注/Memo:
通信作者:马晓庆,Email:984654637@qq.com
基金项目:济宁市重点研发计划项目(2021YXNS123)
更新日期/Last Update: 2023-05-20